Finance entity
Every one of those 1 sits in a single category, earnings. Collegium Pharmaceutical is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 5.2 in the same window.
Last mentioned: Aug 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, earnings. Collegium Pharmaceutical is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 5.2 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. We currently track 1 Finance story that mention Millennium Management LLC, all published on August 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Millennium Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Collegium Pharmaceutical delivered an 11.6% EPS beat and modest revenue beat, lifting shares to $29.47. High ROE and institutional accumulation offset by high leverage and mixed analyst ratings create a nuanced investment case.
Millennium Management LLC is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
